Anna Sureda

Anna Sureda

UNVERIFIED PROFILE

Are you Anna Sureda?   Register this Author

Register author
Anna Sureda

Anna Sureda

Publications by authors named "Anna Sureda"

Are you Anna Sureda?   Register this Author

100Publications

4021Reads

21Profile Views

m7FLIPI and targeted sequencing in high-risk follicular lymphoma.

Hematol Oncol 2019 Sep 2. Epub 2019 Sep 2.

Department of Clinical Hematology, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2674DOI Listing
September 2019

Neutropenia during frontline treatment of advanced Hodgkin lymphoma: Incidence, risk factors, and management.

Crit Rev Oncol Hematol 2019 Jun 29;138:1-5. Epub 2019 Mar 29.

Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), 350 Massachusetts Avenue, Cambridge, MA, 02139, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428183013
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2019.03.016DOI Listing
June 2019

Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.

Br J Haematol 2019 Mar 17;184(6):999-1005. Epub 2018 Dec 17.

Department of Haematology, University College London Cancer Institute, London, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.15723
Publisher Site
http://dx.doi.org/10.1111/bjh.15723DOI Listing
March 2019

Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies.

Bone Marrow Transplant 2019 01 24;54(1):17-25. Epub 2018 May 24.

Division of Hematology Oncology, Blood and Marrow Transplant Program, University of Pennsylvania and Perelman School of Medicine, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0214-5DOI Listing
January 2019

Safety Analysis of Brentuximab Vedotin from the Phase III AETHERA Trial in Hodgkin Lymphoma in the Post-Transplant Consolidation Setting.

Biol Blood Marrow Transplant 2018 11 30;24(11):2354-2359. Epub 2018 May 30.

Department of Hematology and Blood and Marrow Transplant, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.05.026DOI Listing
November 2018

Brentuximab vedotin for lymphoma in paediatric patients.

Lancet Haematol 2018 10;5(10):e433-e434

Clinical Hematology Department, Institut Català d'Oncologia, Barcelona 08908, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026183016
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(18)30160-1DOI Listing
October 2018

Reply to the persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphoma.

Cancer 2018 08 7;124(16):3455-3456. Epub 2018 Jun 7.

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31564DOI Listing
August 2018

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.

Biol Blood Marrow Transplant 2018 01 13;24(1):78-85. Epub 2017 Oct 13.

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743624PMC
January 2018

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome.

Hematol Oncol 2017 Dec 3;35(4):520-527. Epub 2017 Feb 3.

Department of Clinical Hematology. ICO-Badalona, Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2378DOI Listing
December 2017

Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas.

J Clin Apher 2017 Oct 10;32(5):295-301. Epub 2016 Sep 10.

Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jca.21506DOI Listing
October 2017

Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

J Clin Oncol 2017 Oct 28;35(30):3425-3432. Epub 2017 Aug 28.

Carmen Martínez, Institute of Hematology and Oncology, Hospital Clínic; Carmen Canals, Banc de Sang i Teixits; Anna Sureda, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona; Jorge Gayoso, Hospital General Universitario Gregorio Marañón, Madrid; Arancha Bermúdez, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain; Carmen Martínez, Hervé Finel, Silvia Montoto, Peter Dreger, and Anna Sureda, European Society for Blood and Marrow Transplantation, Paris; Didier Blaise, Institut Paoli Calmettes, Marseille; Edouard Forcade, University Hospital of Bordeaux, Bordeaux; Ibrahim Yakoub-Agha, Centre Hospitalier Regional Universitaire de Lille, Lille Inflammation Research International Center, Institut National de la Santé et de la Recherche Médicale U995, Lille, France; Karl Peggs, University College London Cancer Institute; Michael Potter, The Royal Marsden Hospital; Silvia Montoto, St Bartholomew's Hospital, Barts Health National Health Service Trust, London; Stephen Robinson, Bristol Haematology and Oncology Centre, Bristol; Grant McQuaker, Gartnaval General Hospital, Glasgow; Adrian Bloor, Christie National Health Service Trust Hospital, Manchester, United Kingdom; Alida Dominietto, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Azienda Ospedaliera-Universitaria San Martino-IST, Genova; Luca Castagna, Istituto Clinico Humanitas; Paolo Corradini, Istituto Nazionale dei Tumori, Milan; Domenico Russo, University of Brescia, Brescia, Italy; Boris Afanasyev, First Pavlov State Medical University of St Petersburg, St Petersburg, Russia; Maija Itälä-Remes, Turku University Hospital, Turku, Finland; Christof Scheid, University of Cologne, Cologne; and Peter Dreger, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6869DOI Listing
October 2017

Update on diagnosis and treatment of adult T-cell leukaemia/lymphoma.

Med Clin (Barc) 2017 Feb 30;148(4):176-180. Epub 2016 Nov 30.

Unitat Funcional de Limfomes, Servei d'Hematologia, Institut Català d'Oncologia, Hospital Duran i Reynals, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.10.005DOI Listing
February 2017

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.

Leuk Lymphoma 2017 01 17;58(1):222-225. Epub 2016 May 17.

a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1182164DOI Listing
January 2017

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012706PMC
September 2016

[Mobilization of peripheral blood stem cells with plerixafor in poor mobilizer patients].

Med Clin (Barc) 2016 Sep 30;147(5):223.e1-223.e7. Epub 2016 Jun 30.

Servicio de Hematología, Institut Català d'Oncologia (ICO)-Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.05.019DOI Listing
September 2016

Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?

Mycoses 2016 Aug 30;59(8):516-9. Epub 2016 Mar 30.

Department of Haematology, Catalan Institute of Oncology - Hospital Duran i Reynals, Biomedical Research Institute of Bellvitge (Idibell), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12500DOI Listing
August 2016

Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.

J Clin Oncol 2016 06 25;34(17):2028-36. Epub 2016 Apr 25.

Patrice Carde and Christophe Ferme, Gustave Roussy Cancer Campus, Villejuif; Pauline Brice, Hopital St. Louis, Paris; Olivier Casasnovas and Denis Caillot, Centre Hospitalier Universitaire (CHU) de Dijon, Dijon; Isabelle Gaillard, CHU Henri Mondor, Creteil; Serge Bologna, Centre Hospitalier Regional Universitaire (CHR) de Nancy, Nancy; Frank Morschhauser, CHR de Lille, Lille; Bertrand Coiffier, CHU de Lyon, Lyon; Nicolas Mounier, Hopital de L'Archet, Nice, France; Matthias Karrasch and Catherine Fortpied, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Hussein Khaled, National Cancer Institute, Cairo, Egypt; Pieternella Johanna Lugtenburg, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Igor Aurer, University Hospital Centre Zagreb, Zagreb, Croatia; Ralph Meyer, Juravinski Cancer Centre, Hamilton, Ontario; Matthew Seftel, Cancer Care Manitoba, Winnipeg, Manitoba, Canada; Max Wolf, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia; Bengt Glimelius, Uppsala University, Uppsala, Sweden; and Anna Sureda, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5648DOI Listing
June 2016

Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease.

Croat Med J 2016 Jun;57(3):247-54

Isabel Sánchez-Ortega, Department of Hematology, ICO - Hospital Duran i Reynals, Gran Via de L'Hospitalet, 199-203, Barcelona 08908, Spain,

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937227PMC
http://dx.doi.org/10.3325/cmj.2016.57.247DOI Listing
June 2016

Mesenchymal stromal cells for steroid-refractory acute GVHD.

Lancet Haematol 2016 Jan 27;3(1):e8-9. Epub 2015 Nov 27.

Hematology Department, Institut Català d'Oncologia, 08908 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12185-010-0606
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S235230261500252
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(15)00252-5DOI Listing
January 2016

The role of allogeneic stem cell transplantation in Hodgkin's lymphoma.

Curr Treat Options Oncol 2014 Jun;15(2):238-47

Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals, Avda. Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11864-014-0287
Web Search
http://link.springer.com/10.1007/s11864-014-0287-3
Publisher Site
http://dx.doi.org/10.1007/s11864-014-0287-3DOI Listing
June 2014

Lymphoma-directed conditioning for aggressive lymphoma.

Authors:
Anna Sureda

Lancet Oncol 2014 Jun 11;15(7):678-9. Epub 2014 May 11.

Haematology Department, Institut Catala D'Oncologia, L'hospitalet de Llobregat, 08908 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70232-3DOI Listing
June 2014

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma.

Br J Haematol 2014 Jan 1;164(1):39-52. Epub 2013 Oct 1.

Department of Haematology, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12582DOI Listing
January 2014

Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.

Leuk Lymphoma 2013 Aug 1;54(8):1706-12. Epub 2013 Feb 1.

Department of Hematology, Althaia, Universitat Internacional de Catalunya, Manresa, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.752080DOI Listing
August 2013

The role of hematopoietic stem cell transplantation in the treatment of relapsed/refractory Hodgkin's lymphoma.

Curr Opin Oncol 2012 Nov;24(6):727-32

Addenbrookes Hospital, University of Cambridge, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328359557eDOI Listing
November 2012

The evolving role of stem cell transplants in lymphomas.

Biol Blood Marrow Transplant 2012 May 1;18(5):660-73. Epub 2011 Oct 1.

Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.09.009DOI Listing
May 2012

Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2009 Nov 1;15(11):1439-46. Epub 2009 Sep 1.

Hematology Department and Stem Cell Transplantation Program, Hospital de Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910900342
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2009.07.013DOI Listing
November 2009